ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO317

Tubulo-Glomerular Feedback Independent Hypertension and Kidney Interstitial Fibrosis in DOCA-Salt Mice

Session Information

Category: Hypertension and CVD

  • 1403 Hypertension and CVD: Mechanisms


  • Shi, Xiaoxiao, Peking Union Medical College Hospital, Beijing, BEIJING, China
  • Peng, Xiaoyan, Peking Union Medical College Hospital, Beijing, BEIJING, China
  • Tian, Dongli, Peking Union Medical College Hospital, Beijing, BEIJING, China
  • Xia, Peng, Peking Union Medical College Hospital, Beijing, BEIJING, China
  • Wen, Yubing, Peking Union Medical College Hospital, Beijing, BEIJING, China
  • Chen, Limeng, Peking Union Medical College Hospital, Beijing, BEIJING, China

Group or Team Name

  • Peking Union Medical College Hospital Kidney Lab

Sodium transporters and tubulo-glomerular feedback (TGF) play important roles in sodium balance and blood pressure maintanence. Renal adenosine-A1 adenosine receptor (A1AR) pathway, which is mediated by Na-K-Cl cotransporter 2 (NKCC2), is involved in the classic TGF mechanism. This study was to observe the role of sodium transporters and A1AR in salt-sensitive hypertension and associated kidney injury.


Deoxycorticosterone acetate (DOCA)-salt hypertensive mouse model was established by removal of left kidney, implantation of a DOCA pellet (200mg, 60-day release), and feeding with high salt diet (8%NaCl). Arterial blood pressure and urine electrolyte excretion were determined. Pathological changes, protein and mRNA expression of sodium transporters and adenosine-A1AR pathway were measured in mice kidney.


DOCA-salt and uni-nephrectomy treatment in wildtype C57BL/6J mice led to continuous higher blood pressure, accompanied by obvious tubulo-interstitial injury and interstitial fibrosis at different ages (4w, 8w). In DOCA-salt wildtype mice, the Na+-Cl- cotransporter (NCC) and NKCC2 upregulation (1.6-1.75 times) were observed in kidney, with activation of adenosine-A1AR pathway (mRNA expression of adenosine synthetase CD73 and A1AR about 2-3 times increased). DOCA-salt mice also showed signs of glomerular hyperperfusion and hyperfiltration, which included polyuria, increased urine sodium excretion and kidney enlargement. Compared with DOCA-salt wildtype mice, the DOCA-salt A1AR-/- mice presented more severe glomerular hyperperfusion and hyperfiltration (including polyuria and increased urine sodium excretion). However, DOCA-salt A1AR-/- mice showed the same degree of hypertension (4w: 125.7±7.4 vs. 127.4±18.8 mmHg; 8w: 135.3±5.2 vs. 141.7±9.5 mmHg; P>0.05 both) and renal interstitial fibrosis (4w: 2.05±1.73% vs. 1.52±1.44%; 8w: 10.35±4.86 vs. 9.42±5.95%; P>0.05 both), which were compliant with the change of NCC protein expression (4w 1.65 ± 0.19 vs.1.70 ± 0.18; 8w 1.47 ± 0.21 vs 1.00 ± 0.34, P>0.05 both).


DOCA-salt treatment in mice induced hypertension and kidney interstitial fibrosis. The mechanism may lie in NCC activation, instead of NKCC2 associated TGF.


  • Government Support - Non-U.S.